The non-hydrolysable guanine analogues guanosine 5'-[y-thio]triphosphate (GTP[S] 
INTRODUCTION
One of the important events that follows an agonistreceptor interaction at the surface of many activatable cells is the phospholipase C-catalysed hydrolysis of phosphatidylinositol 4,5-bisphosphate [1] [2] [3] . Both [4] [5] [6] . Studies on chick heart cells [7] , rat liver membranes [8] and platelet plasma membranes [9] all support the involvement of a GTP-binding protein in the membrane signal-transduction process (see also review by Cockcroft [10] ), but exactly how this protein and its associated subunits regulate the phosphodiesterase activity has not yet been clearly defined.
In whole platelets in which the plasma membrane has been permeabilized by electrically-induced pore formation, GTP [S] has been shown to greatly enhance the Ca2"-sensitivity for 5-hydroxytryptamine (5HT) secretion, and is also associated with an increased formation of diacylglycerol [11] . This GTP[S]-induced secretion phenomenon is essentially the same as that seen with certain agonists or with the addition of a synthetic analogue of diacylglycerol, oleoylacetylglycerol [12, 13] .
Using a different permeabilization procedure, involving controlled exposure to saponin, we and others have reported that permeabilized platelets can be stimulated by Ins (1, 4, 5) P3 to -release Ca2" from intracellular stores [14] [15] [16] [17] . The [14, 15, 17] . This response is expressed as shape change, aggregation and the secretion of granule-stored 5- 
hydroxy[14C]tryptamine (['4C]5HT).
Recently we reported, in abstract form, that GTP[S] also induces similar aggregation and secretion responses in permeabilized platelets by activation of phospholipase C, probably through the effect of the nucleotide analogue on a GTP-binding protein at an intracellular site [18] . These GTP[S]-induced responses can be totally inhibited by pretreatment of the platelets with guanosine 5'-[/-thio]diphosphate (GDP [S] ) before saponin treatment [18] . We also reported that GDP [S] was very effective at inhibiting platelet responses to low doses of thrombin and collagen in permeabilized cells and showed, for the first time to our knowledge, that GDP[S] was as effective on intact platelets as on the permeabilized platelets. We now report our detailed studies of these investigations, and include also further studies on the possible sites of action for the GDP[S] effects on intact platelets. Our studies suggest that some caution may be necessary when exploring the role of G-proteins in platelet function by use of GDP [S] , although at present this is perhaps the best available inhibitor of G-protein functions.
MATERIALS AND METHODS

Materials
All experiments were carried out in solutions made up in AnalaR-grade water (BDH, Poole, Dorset, U.K.). Indomethacin, prostaglandin E1, saponin, human thrombin, GTP and GDP[S] were obtained from Sigma Chemical Co., Poole, Dorset, U.K., and GTPyS was obtained from Boehringer Corp. (London), Lewes, E. Sussex, U.K. Ins(1,4,5)P3 was isolated from human red cells by the procedure of Downes et al. [19] as modified by Irvine et al. [20] . Preparation of washed human platelet suspensions
The collection of fresh human blood, preparation of platelet-rich plasma, prelabelling with 5-hydroxy["4C]-tryptamine (["4C]5HT) and washing of the platelets were carried out exactly as described by Authi et al. [14, 15] . The platelets were finally resuspended at a concentration of 2.5 x 108 cells/ml in a medium of the following composition: 140 mM-KCl, I mM-glucose, 1 mM-MgCl2, 0.42 mM-NaH2PO4, 6 mM-NaHCO3 and 10 mM-Hepes made up in AnalaR water and buffered to pH 7. 4 experiments involving secretion of 5HT from [14C}5HT-labelled cells, imipramine (2 /LM) was added to the cell suspension 2 min before addition of saponin, to inhibit amine re-uptake. After the 4 min recording, reactions were terminated by adding 500 1d of 3 O0 (v/v) glutaraldehyde containing 6 mM-EDTA and 150 mM-KCI buffered to pH 7.4 with Hepes. The fixed cell suspensions were centrifuged at 12000 g for 3 min and the released ["4C]-5HT in the supernatant was determined by liquidscintillation counting. Released 5HT was expressed as a percentage of that released by total lysis of an equivalent volume of non-permeabilized unfixed cell suspension.
I3PlPhosphate incorporation and assay of I3Plphosphatidic acid production Platelets were isolated from platelet-rich plasma by centrifugation (1200 g for 10 min) and resuspended in a medium containing 145 mM-NaCl, 5 mM-KCI, 1 mMMgSO4, 10 mM-glucose, I mM-EGTA and 10 mM-Pipes, adjusted to pH 6.8. Apyrase (Grade V; Sigma) was added to a concentration of 0.1 mg/ml of suspension, and finally [32P]Pi (0.2 mCi/mI) was added. The mixture was incubated for I h at 37°C, and after equilibration to room temperature the 32P-labelled cell suspension was acidified to pH 6.5 with 0.3 M-citric acid and centrifuged to deposit the cells (500 g for 20 min). The cells were resuspended in high-KCI permeabilizing medium at a concentration of 2.5 x 108 cells/ml, and the saponin permeabilization and/or aggregation procedures were carried out exactly as described above. In these studies, however, reactions were terminated by the addition of 3 ml of chloroform/methanol/conc. HCI (20: 40: 1, by vol.). Lipid extraction was performed by the procedure of Billah & Lapetina [21] , and the extracts were separated on t.l.c. plates which had been previously impregnated with 1 % potassium oxalate / 2 mM-EDTA, pH 6.5. The solvent system was chloroform/ methanol/4 M-NH3 (9:7:2, by vol.). Areas corresponding to [32p]_ phosphatidic acid were identified by autoradiography overnight, and comparison was made with a similarly chromatographed standard phospholipid mixture after scraping off the appropriate zones and liquid-scintillation counting.
Measurement of intracellular ICa2"I (ICa2+I;) with Fura-2
Labelling of the platelets with the fluorescent dye Fura-2 acetoxymethyl ester was carried out exactly as described by Rao et al. [22] . Briefly, after the cells had been washed free of excess dye, they were resuspended in a buffer consisting of 145 mM-NaCI, I mM-MgSO4, 0.5 mM-NaH2PO4, 5 mm-glucose, t mM-Ca2' and. 10 mMHepes adjusted to pH 7.55. Fluorescence measurements were made in a Perkin-Elmer LS SB spectrofluorimeter, and the Ca2" concentration was calculated by the procedure of Grynkiewicz et al. [23] . Fig. 1(a) Responses to GTP[S] were also observed with higher concentrations of saponin (16) (17) (18) (19) ,ug/mI) under conditions where 70-800 of previously incorporated [3H]-adenine metabolites (primarily ATP) are released into the medium (Authi et al. [14] ). However, here the highsaponin controls gave a greater increase in lighttransmission than when saponin was added in the 14 jug/ ml range. Another non-hydrolysable GTP analogue, guanosine 5'-[/Jy-imido]triphosphate, gave (only occasionally) very weak aggregation responses and secretion, usually 100 above those of control platelets treated only with saponin. These weak effects, however, were not reproducible with different platelet preparations.
RESULTS
Stimulation
GTP tested up to a concentration of 135 /M on saponized platelets (14 ,tg of saponin/ml) produced no functional responses (aggregation or secretion), and the traces were essentially the same as those seen with the saponin-only controls.
Inhibition by GDPISI of GTPISI-induced activation of saponin-permeabilized platelets GDP [S] has been reported to be the best structurally related inhibitor of the action of GTP[S] in permeabilized neutrophils [24] . Effect of GDPISI on GTPISI-induced formation of 132P1-phosphatidic acid in saponin-permeabilized platelets
The incorporation of 32p into the phosphatidic acid formed after an activation stimulus to cells has been extensively used as an index of phospholipase C activity (see [25] The effect of GDP[S] on the platelet aggregation and secretion responses to a conventional surface-membrane agonist, thrombin, was also investigated by using the same saponin-permeabilization protocol as described above. 255 the emission signal when the sample is excited at 340 nm and a decrease in emission at an excitation wavelength of 380 nm with increased [Ca2"],. Fig. 3(a) shows these spectral changes in Fura-2-loaded platelets exposed to thrombin when the fluorescence emission is scanned through the excitation-wavelength range 300-400 nm. It can be seen, by comparison with the control trace, that thrombin added to the intact platelets markedly increased the fluorescence signal emitted at an excitation wavelength of 340 nm. The addition of GDP[S] 3 min before addition of the agonist inhibited the effect of thrombin and gave a trace closely approximating to that of the control platelets. This inhibition by GDP[S] of a thrombin-induced rise in [Ca2"], as reflected in the fluorescence emission changes was dose-dependent. Fig. 3(b) shows the values for cytosol [Ca2"] calculated by the previous procedures [23, 26] . In the control experiments 0.2 unit of thrombin/ml induced a rise in cytosol Fig. 3(c) ference in the Fura-2 assay was similarly excluded. Of other nucleoside phosphates tested (at 1.5 mm concentrations), GDP showed a minor inhibitory effect (16%) and GTP had no effect on thrombin-induced Ca2l mobilization (results not shown).
Since Ca2"-influx channels are known to be activated by ADP [27] , experiments were performed in the presence of an enzyme scavenger system for released ADP. The results presented in Table 3 for two platelet preparations show that in the presence of phosphocreatine (4 mM) and creatine kinase (2 Table 3 ). This would suggest that released ADP plays only a minor role in responses induced by thrombin.
Effect of GDPIS] on the influx of Ca2l through the plasma membrane
In an attempt to define the site of action on the intact platelet ofGDP[S] for its effect in inhibiting the thrombininduced rise in cytosolic [Ca2"], the change in fluorescent signal (wavelength 340 nm) was studied with either 1 mM-Ca2" in the surrounding medium or I mM-EGTA. In the presence of 1 mm external Ca2", 0.2 unit of thrombin/ml induced a rapid rise in the fluorescence emission signal, which then decreased gradually over the succeeding 4 min (Fig. 4a) . Pretreatment with GDP[S] (1 mM) before exposure to the agonist substantially decreased the fluorescence signal. However, with 1 mM-EGTA in the external medium, where the height of the initial rise in fluorescent emission was significantly lower than that in the presence of external 1 mm Ca2" (Fig. 4b) , the pretreatment with GDP[S] had little effect either on the initial fluorescence response or on the rate of decrease of the signal over the course of the following 1 min. In a further -experiment with 1 mM-Ca2" in the medium, GDP[S] was added to cells in the fluorimeter cuvettes just after the addition of thrombin and as close as possible to the peak of the rise in the Ca2"-fluorescence signal. GDP[S] substantially accelerated the rate at which the emission decreased over the following 4 min (Fig. 4c) .
In a further series of experiments, bivalent-cation influx was investigated by the Mn2+-quenching procedure of Hallam & Rink [28] , by using quin-2-labelled cells. changes induced by thrombin Reaction conditions were similar to those in Fig. 3 , except that platelets were loaded with quin-2 instead of Fura-2. All incubations contained 1 mM-Ca2+, and on the indicated traces GDP[S] and Mn2+ were added 3 min before thrombin. Traces are typical of at least three determinations. [29] [30] [31] . Strong evidence is emerging for G-protein involvement in at least some of the agonist-induced responses. Although caution may be required in interpreting data from permeabilized cell preparations, such model systems are now widely used for studies involving the control of the concentration of cytosol constituents and for investigations on the intracellular action of nonmembrane-penetrating molecules. We, and others, have previously shown that Ins(1,4,5)P3 can be introduced into saponin-permeabilized platelets and, through its direct action on intracellular Ca2" stores, initiate release of the cation and trigger intracellular processes. These then lead to a full expression of functional responses, such as aggregation and secretion [14] [15] [16] [17] .
In keeping with its inhibition of phosphoinositide metabolism, and that at higher thrombin concentrations (> 0.5 unit/ml) secretion and fibrinogen-receptor expression [36] were restored, but phosphoinsitide metabolism was still inhibited. This suggests that secretion and fibrinogen binding can occur through a phosphoinositideindependent mechansim. Our data would support this concept only in part, since at low thrombin concentrations (< 0.2 units/ml) secretion, aggregation and phospholipase C activation are all inhibited totally by GDP[S], whereas at high thrombin concentrations both the phosphoinositide metabolism and secretion are restored. We therefore suggest that at high thrombin concentrations (e.g. 2 units/ml) phospholipase C activation may also occur through a G-protein-independent mechanism, explaining the lack of an effect by GDP[S] under these conditions. Several recent reports provide some support for this view. In studies by Oberdisse & Lapetina [31] using saponin-permeabilized platelets GDP[S] failed to inhibit thrombin (1 unit/ml)-induced release of [3H]inositol phosphates, and in fact enhanced it to some degree, even though GDP[S] was effective in inhibiting GTP[S]-stimulated inositol phosphate release. They suggested that perhaps two types of phospholipase C enzyme may exist: one which is stimulated by G-protein and one which is stimulated by other mechanisms. What these other mechanisms may be is at present unknown, but one possibility is that high concentrations of thrombin are able to induce phospholipase C activation and 5HT secretion via a proteinase action. Indeed, in one recent study [37] Ca2" present on the outside of the cell, then the result is further to suppress Ca2" entry, and there is an apparent enhancement of the removal of Ca2" from the cytosol.
The effect cannot be attributed to chelation of Ca"+ by the nucleotide analogue, since higher concentrations of extracellular Ca2l (3 mM) have no effect on the inhibitory action of GDP [S] . Moreover, neither GDP nor GTP has any significant inhibitory effects. Thus GDP[S] may modulate the status ofa thrombin-regulated Ca2" channel in the plasma membrane. Further support for this concept is provided by the Mn2+-quenching experiment. The ability of Mn2" to quench quin-2 fluorescence has been used to monitor agonist-induced bivalent-cation entry into cells [28] . In Recently two other reports have been published concerning the use of GDP [S] with platelet function in agreement with our findings. The first highlights nonspecific inhibitory properties of GDP[S] on intact platelets [38] , and the second reports that inhibition of phospholipase C activity by GDP[S] is only seen in permeabilized platelets [39] . This work is supported by the British Heart Foundation. We express our appreciation to Dr. J. Westwick for many helpful discussions of this work, and to Miss H. Watson for her help in preparing the manuscript.
